Deutsch English Français

Contact

EP2771012

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2771012

EP2771012 - NEW COMPOUNDS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 10.06.2016 Database last updated on 06.07.2024
Most recent event Tooltip	10.06.2016	Application deemed to be withdrawn	published on 13.07.2016 [2016/28]
Applicant(s)	For all designated states GlaxoSmithKline Intellectual Property (No. 2) Limited 980 Great West Road Brentford, Middlesex TW8 9GS / GB
	[2016/21]
Former [2014/36]	For all designated states Glaxosmithkline Intellectual Property (No. 2) Limited 980 Great West Road Brentford, Middlesex TW8 9GS / GB
Inventor(s)	01 / HENDRICKSON, Thomas, Francis 5852 Crest Drive Encinitas, CA 92024 / US
	02 / HO, Koc-Kan 2836 Valley View Avenue Holladay, UT 84417 / US
	03 / SAUNDERS, Michael, David 10864 Berrywood Court Sandy, UT 84070 / US
	04 / STEVENS, Brian, John 1766 East Princeton Avenue Salt Lake City, UT 84108 / US
	05 / SWIERCZEK, Krzysztof 7843 Tiger Court West Jordan, UT 84081 / US
	06 / WRIGHT, Kevin, Bret 9018 Kings Hill Place Cottonwood Heights, UT 84121 / US
	[2014/36]
Representative(s)	Reed, Michael Antony GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB
	[2014/36]
Application number, filing date	12843835.5	23.10.2012
	WO2012US61439
Priority number, date	US201161550679P	24.10.2011 Original published format: US 201161550679 P
	[2014/36]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2013062943
	Date:	02.05.2013
	Language:	EN
	[2013/18]
	Type:	A1 Application with search report
	No.:	EP2771012
	Date:	03.09.2014
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 02.05.2013 takes the place of the publication of the European patent application.
	[2014/36]
Search report(s)	International search report - published on:	US	02.05.2013
	(Supplementary) European search report - dispatched on:	EP	28.05.2015
Classification	IPC:	A61K31/52, C07D473/34, C07H19/16, A61P35/00	[2015/26]
	CPC:	C07D473/34 (EP,US); C07H19/16 (US); A61K31/7052 (EP,US); A61K31/706 (EP,US); A61K31/7064 (EP,US); A61K31/7076 (EP,US); (+) A61P35/00 (EP) (-)
	Former IPC [2014/36]	A61K31/52
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/36]
Extension states	BA	22.04.2014
	ME	22.04.2014
Title	German:	NEUE VERBINDUNGEN	[2014/36]
	English:	NEW COMPOUNDS	[2014/36]
	French:	NOUVEAUX COMPOSÉS	[2014/36]
Entry into regional phase	22.04.2014	National basic fee paid
	22.04.2014	Search fee paid
	22.04.2014	Designation fee(s) paid
	22.04.2014	Examination fee paid
Examination procedure	22.04.2014	Amendment by applicant (claims and/or description)
	22.04.2014	Examination requested [2014/36]
	05.01.2016	Application deemed to be withdrawn, date of legal effect [2016/28]
	02.02.2016	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/28]
Fees paid	Renewal fee
	07.10.2014	Renewal fee patent year 03
	07.10.2015	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO0140799 (CV THERAPEUTICS INC [US], et al) [X] 1-4,7,8,10,14 * pages 8f; formula 1; compounds (27) and (28) in example 4 on pages 54f *;
		[X]WO03074083 (PFIZER [US], et al) [X] 1-3,6-8,10,13-15 * the whole document, in particular the claims; examples 2(B)6, 2(B)14, 2(F)3, 2(F)16, 2(F)19, 2(G)9, 2(G)61, 2(G)69 *;
		[X]WO2004016635 (CV THERAPEUTICS INC [US]) [X] 1,2,6-8,10,13,14 * in particular claims 1 and 20; example 9; page 55 *;
		[X]WO2007067559 (UNIV MINNESOTA [US], et al) [X] 1-3,7,10,13,14 * claims; compounds 139 and 146 in examples 15 and 16 and in schemes 16 and 17 *;
		[X] - KUNG P P ET AL, "Design, synthesis, and biological evaluation of novel human 5'-deoxy-5'-methylthioadenosine phosphorylase (MTAP) substrates", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 15, no. 11, ISSN 0960-894X, (20050602), pages 2829 - 2833, (20050602), XP027801098 [X] 1-4,6,10,14,15 * the whole document, in particular second paragraph in right-hand column on page 2832; compounds 17 and 24 in table 2 *
		[X] - MALIK A ET AL., "Coumaroyl Adenosine and Lignan Glycoside from Amaranthus spinosus L.", POLISH JOURNAL OF CHEMISTRY, (2006), vol. 80, pages 259 - 263, XP002739312 [X] 1-3,7,10,13,14 * compound 2 on pages 260-263; page 259 first paragraph; page 263 "extraction and isolation" *
		[X] - MORIS F ET AL, "A USEFUL AND VERSATILE PROCEDURE FOR THE ACYLATION OF NUCLEOSIDES THROUGH AN ENZYMIC REACTION", THE JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19930101), vol. 58, no. 3, doi:10.1021/JO00055A018, ISSN 0022-3263, pages 653 - 660, XP009054627 [X] 1-3,7,9,10 * schemes I and II; entry 8 in table III, entry 3h in table IV and entries 7g and 7h in table VII as well as on pages 658-660 * DOI: http://dx.doi.org/10.1021/jo00055a018
		[X] - ANDREW MARSH ET AL, "Atom Transfer Polymerization: Use of Uridine and Adenosine Derivatized Monomers and Initiators", MACROMOLECULES, (19991201), vol. 32, no. 26, doi:10.1021/ma991438q, ISSN 0024-9297, pages 8725 - 8731, XP055187711 [X] 1-3,7,10 * compound 5 in figures 1,2 and on page 8726 * DOI: http://dx.doi.org/10.1021/ma991438q
		[X] - AFZAL KHAN ET AL, "Hydrogen Bond Template-Directed Polymerization of Protected 5'-Acryloylnucleosides", MACROMOLECULES, (19991001), vol. 32, no. 20, doi:10.1021/ma990283j, ISSN 0024-9297, pages 6560 - 6564, XP055187885 [X] 1-3,7,9,10 * scheme 1 with B=adenine; page 6561, left-hand column, third paragraph; second pararaph on the right-hand column of the same page * DOI: http://dx.doi.org/10.1021/ma990283j
		[X] - TAKAMURA T ET AL, "Synthesis and antitumor activities of N6,N6-dimethyladenosine carboxylate analogues", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, JP, (19890101), vol. 37, no. 10, ISSN 0009-2363, pages 2828 - 2831, XP002181857 [X] 1,2,10,14,15 * compound 3q in chart 1, table I and right-hand column on page 2830; table II a) *
		[X] - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20020905), Database accession no. 446850631, XP002739313 [X] 1-3,7,9,10 * compound with registry number 446850-63-1 *
	International search	[Y]US2008132525 (WAHHAB AMAL [CA], et al);
		[Y] - SIEDLECKI ET AL., "Establishment and functional validation of a structural homology model for human DNA methyltransferase 1", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (20030627), vol. 306, no. 2, pages 558 - 563, XP055066318 DOI: http://dx.doi.org/10.1016/S0006-291X(03)01000-3
		[A] - COHEN ET AL., "Determinants of cofactor binding to DNA methyltransferases: insights from a systematic series of structural variants of S-adenosylhomocysteine", ORG.BIOMOL.CHEM., (2005), vol. 3, no. 1, pages 152 - 161, XP002412376 DOI: http://dx.doi.org/10.1039/b415446k
		[A] - YANG ET AL., "Structure of the bacteriophage T4DNA adenine methyltransferase", NATURE STRUCTURAL BIOLOGY, (200310), vol. 10, no. 10, pages 849 - 855, XP008119541 DOI: http://dx.doi.org/10.1038/nsb973

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p